Henry Schein Inc (HSIC) is a publicly traded Healthcare sector company. As of July 9, 2026, HSIC trades at $83.28 with a market cap of $9.89B and a P/E ratio of 27.48. HSIC moved -4.11% today. Year to date, HSIC is +10.11%; over the trailing twelve months it is +12.54%. Its 52-week range spans $60.56 to $89.29. Analyst consensus is buy with an average price target of $87.50. Rallies surfaces HSIC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for HSIC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $83.28 |
| Market Cap | $9.89B |
| P/E Ratio | 27.48 |
| EPS | $3.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $89.29 |
| 52-Week Low | $60.56 |
| Volume | 1.21M |
| Avg Volume | 0 |
| Revenue (TTM) | $12.67B |
| Net Income | $398.00M |
| Gross Margin | 31.69% |
13 analysts cover HSIC: 0 strong buy, 8 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $87.50.